Listar Artículos de revista DCS - OZS Aldizkari artikuluak por tema "ADAM12"
Mostrando ítems 1-1 de 1
-
ADAM12 is a potential therapeutic target regulated by hypomethylation in triple-negative breast cancer
Triple-negative breast cancer (TNBC) is the most aggressive breast cancer subtype and currently lacks any effective targeted therapy. Since epigenetic alterations are a common event in TNBC, DNA methylation profiling can ...